Png, M., Harris, V., Grabey, J., Jani, B., Butler, D., Carson-Stevens, A., Coates, M., Cureton, L., Dobson, M., Dorward, J., Evans, P., Francis, N., Hayward, G., Holmes, J., Hood, K., Khoo, S., Ahmed, H., Lown, M., McKenna, M., Mort, S., van Hecke, O., Hobbs, R., Little, P., Yu, L., Petrou, S., Hart, N., Gbinigie, O., Nguyen-Van-Tam, J., Rahman, N., Richards, D., Thomas, N. & Butler, C. 2024, 'Cost-utility analysis of molnupiravir for high-risk, community-based adults with COVID-19: an economic evaluation of the PANORAMIC trial', British Journal of General Practice, 74(745), pp. e570-e579. https://doi.org/10.3399/BJGP.2023.0444